Sunday July 05 2009 |
Biotechnology feed
|
All feeds
Home
Marketing Services
Antibodies
Careers
Directories
Drugs
Events
Genes
InDepth
News
Reports
Videos
A-Z
Business
Health
Drugs
Sources
Americas
Europe
Asia
Cancer
Cardio-
Diabetes
Bird Flu
Swine Flu
Summaries
Post News
Search
BioNews - BioPortfolio's News Portal
Multiple Sclerosis News and Headlines
Sign-up to BioPortfolio's
Multiple Sclerosis news alerts
.
Subscribe to
Multiple sclerosis RSS feed
-
-
View full RSS Index
Subscribe to
BioWatch News Email alerts
-
open
BioWatch PDF brochure
.
Publish your news
using BioNewsCast
- open
BioNewsCast PDF brochure
.
Monthly Steroid Pulses Cut MS Relapses 38 Percent With Few Side Effects, Study Finds
Neurology Today:
similar ...
Brain stem cell discovery could lead to new therapies
Cambridge Network:
similar ...
Insight Into How Brain Stem Cells Develop Into Cells Which Repair Damaged Tissue
Medical News Today:
similar ...
UCB And Biogen Idec Discontinue Phase II Clinical Trial Of CDP323 - Analysis Showed No Clinically Relevant Ben
Medical News Today:
similar ...
Brain stem cell discovery
University of Cambridge:
similar ...
Important Modulator Of Immune Cell Entry Into The Brain Discovered
Medical News Today:
similar ...
Clues to brain cell development, genetics study
Scientist Live:
similar ...
New clue into how brain stem cells develop into cells which repair damaged tissue
EurekAlert!:
similar ...
New clue into how brain stem cells develop into cells which repair damaged tissue
PhysOrg.com:
similar ...
New Discovery Into How Brain Stem Cells Develop Into Cells Which Repair Damaged Tissue
Red Orbit:
similar ...
UCB Group (UCBJF.PK) and Biogen Idec, Inc. (Massachusetts) (BIIB) Discontinue Phase II Clinical Trial of CDP32
BioSpace:
similar ...
UCB And Biogen Idec Discontinue Phase II Clinical Trial Of CDP323
Medical News Today:
similar ...
UCB and Biogen Idec discontinue Phase II clinical trial of CDP323
Houston Chronicle:
similar ...
UCB (BE) - UCB and Biogen Idec Discontinue Phase II Clinical Trial of CDP323
Pharma Live:
similar ...
The Multiple Sclerosis Association of America's Interactive Video Series Wins Prestigious Business Award
Genetic Engineering News:
similar ...
UCB and Biogen Idec discontinue Phase II clinical trial of CDP323
Reuters:
similar ...
UCB and Biogen Idec discontinue Phase II clinical trial of CDP323
EuroInvestor.co.uk:
similar ...
UCB and Biogen Idec discontinue Phase II clinical trial of CDP323
Genetic Engineering News:
similar ...
UCB and Biogen Idec discontinue Phase II clinical trial of CDP323
TradingMarkets:
similar ...
UCB and Biogen Idec discontinue Phase II clinical trial of CDP323
Street Insider:
similar ...
